Skip to content

Architect 2K47-27

by Abbott Ireland Diagnostics

Ref 02K4727Model 2K47-27

Architect 2K47-27 (02K4727) is an in vitro diagnostic device (EU IVDD general IVD; FDA Class II; EMDN category thyroid peroxidase (incl. microsomal) antibodies) made by Abbott Ireland Diagnostics, registered in EUDAMED on 30 Oct 2026 (Basic UDI-DI B-00380740048327) and listed in FDA GUDID since 6 Jun 2016 (UDI-DI 00380740048327), active as of 7 Nov 2026.

Active European Union. Also listed in GUDID (US).

CE IVDD

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, GUDID, synced 7 Nov 2026.

Regulatory status

as of registry sync 7 Nov 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD EUDAMED NumberB-00380740048327 Basic UDI-DI 00380740048327UDI-DIDate30 Oct 2026RegisteredStatusActive
United StatesGUDID listing GUDID Number00380740048327 UDI-DI Date6 Jun 2016ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
ARCHITECT Anti-TPO Reagent Kit
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 7 Nov 2026, as the labeller entered it.

Across registries

2 registries list this device

  • EUDAMED Basic UDI-DI B-00380740048327 registered 30 Oct 2026 Active
  • FDA GUDID UDI-DI 00380740048327 listed 6 Jun 2016 Listed

Timeline

2 dated events

  1. Listed FDA GUDID 00380740048327
  2. Registered EUDAMED B-00380740048327

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDD Active
  • United States GUDID listing Listed

Specification

EUDAMED · GUDID

Trade name
Architect
Generic name
Thyroid peroxidase antibody (anti-TPO/microsomal antibody) IVD, kit, chemiluminescent immunoassay
Device name
Anti-TPO
Model / Ref / Catalog
2K47-27, 02K4727
Description
ARCHITECT Anti-TPO Reagent Kit
Primary DI / UDI-DI
00380740048327
Basic UDI-DI
B-00380740048327
FDA product code
JZO, JIT, JJX
EMDN code
W0102100301 Thyroid peroxidase (incl. microsomal) antibodies
GMDN term
Thyroid peroxidase antibody (anti-TPO/microsomal antibody) IVD, kit, chemiluminescent immunoassay
Device class
Class IVD General EUDAMED
Class II GUDID
Regulation number
866.5870, 862.1150, 862.1660
EU registration type
Legacy device (under a directive)
EU market of registration
Ireland
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 1 field differs

FieldEUDAMEDGUDID
Device classEUDAMED
Class IVD General
GUDID
Class II

Device class is stated on each registry's own scale: Class IVD General in the EU (EUDAMED), Class II in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Similar devices in this category

Other devices filed under THYROID PEROXIDASE (INCL. MICROSOMAL) ANTIBODIES.

Other devices from Abbott Ireland Diagnostics

See all devices from Abbott Ireland Diagnostics →

Properties

  • Contains human tissues or cells
  • Contains animal tissues or cells
  • Contains substances of microbial origin
  • Reagent
  • IVD kit
  • Professional testing
  • Prescription use
  • Convenience kit
  • Lot / batch number
  • Expiration date
Other properties (16, all answered No)